Click on the company for more information on the subsidy award. Click on the parent name to reach the summary page for that parent company.
Company | Parent | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
---|---|---|---|---|---|---|---|
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | $1,200,000 | tax credit/rebate | ||
Merck & Co., Inc. | Merck | Pennsylvania | state | $1,200,000 | grant | ||
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | $1,200,000 | grant | ||
Novitas Solutions, Inc. | Novartis | Florida | state | 2013 | $1,200,000 | tax credit/rebate | |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2017 | $1,200,000 | tax credit/rebate | |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2011 | $1,196,763 | tax credit/rebate | |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $1,192,386 | tax credit/rebate | |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2008 | $1,187,088 | enterprise zone | |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2015 | $1,170,852 | tax credit/rebate | |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2009 | $1,169,891 | enterprise zone | |
Astellas US LLC | Astellas Pharma | United States | federal | 2013 | $1,160,482 | federal grant | |
Vertex Pharmaceuticals, Inc | Vertex Pharmaceuticals | Massachusetts | state | 2011 | $1,152,515 | tax credit/rebate | |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2008 | $1,152,412 | enterprise zone | |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2015 | $1,150,515 | tax credit/rebate | |
Janssen Biotech Inc | Johnson & Johnson | Pennsylvania | state | 2021 | $1,148,700 | tax credit/rebate | |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2014 | $1,144,884 | tax credit/rebate | |
Novartis #1 | Novartis | New Jersey | state | 2005 | $1,142,400 | Tax credit/rebate | |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2004 | $1,130,588 | enterprise zone | |
Eli Lilly And Company | Eli Lilly | Pennsylvania | state | 2010 | $1,128,200 | tax credit/rebate | |
G.D. SEARLE & COMPANY | Pfizer | Missouri | state | 2002 | $1,126,728 | tax credit/rebate | |
Takeda Pharmaceuticals America, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2016 | $1,125,000 | tax credit/rebate | |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2019 | $1,125,000 | tax credit/rebate | |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2007 | $1,123,304 | enterprise zone | |
Novo Nordisk Pharmaceutical | Novo Holdings A/S | North Carolina | state | 2004 | $1,120,000 | grant | |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2001 | $1,119,362 | tax credit/rebate | |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2017 | $1,113,133 | tax credit/rebate | |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $1,107,208 | enterprise zone | |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $1,107,208 | enterprise zone | |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2009 | $1,105,019 | tax credit/rebate | |
NOVARTIS | Novartis | New York | state | 2006 | $1,100,000 | grant | |
Dey Pharma, L.P., Mylan Inc. and Affiliates | Viatris | New Jersey | state | 2009 | $1,088,479 | grant | |
OSI Pharmaceuticals, Inc. | Astellas Pharma | New York | local | 2005 | $1,079,994 | tax credit/rebate; property tax abatement | |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $1,077,666 | tax credit/rebate | |
Bausch & Lomb Inc. | Bausch Health | New York | local | 2020 | $1,076,396 | tax credit/rebate | |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2020 | $1,065,000 | tax credit/rebate | |
PAREXEL International | Parexel International | Massachusetts | state | 2014 | $1,062,412 | tax credit/rebate | |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2006 | $1,060,334 | tax credit/rebate | |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2007 | $1,060,334 | tax credit/rebate | |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $1,050,000 | tax credit/rebate | |
Abiomed, Inc. | Johnson & Johnson | Massachusetts | state | 2016 | $1,050,000 | tax credit/rebate | |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2016 | $1,045,614 | tax credit/rebate | |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2020 | $1,038,094 | tax credit/rebate | |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2021 | $1,031,751 | tax credit/rebate | |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2014 | $1,028,677 | enterprise zone | |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2015 | $1,026,957 | tax credit/rebate | |
Regeneron Warehouse Expansion | Regeneron Pharmaceuticals | New York | local | 2019 | $1,026,828 | tax credit/rebate | |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2014 | $1,023,131 | tax credit/rebate | |
Synageva BioPharma | AstraZeneca | Massachusetts | state | 2014 | $1,021,550 | tax credit/rebate | |
Pfizer, Inc. | Pfizer | North Carolina | state | 2016 | $1,013,383 | tax credit/rebate | |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $1,009,926 | property tax abatement | |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $1,009,669 | property tax abatement | |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $1,009,639 | property tax abatement | |
Regeneron Warehouse | Regeneron Pharmaceuticals | New York | local | 2017 | $1,008,259 | tax credit/rebate | |
Regeneron Warehouse | Regeneron Pharmaceuticals | New York | local | 2020 | $1,007,951 | tax credit/rebate | |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2019 | $1,007,332 | tax credit/rebate | |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $1,000,000 | infrastructure assistance | |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $1,000,000 | tax credit/rebate | |
Centocor, Inc. | Johnson & Johnson | Pennsylvania | state | $1,000,000 | training reimbursement | ||
Aventis Pasteur Inc. | Sanofi | Pennsylvania | state | $1,000,000 | grant | ||
Novartis Pharmaceuticals Corp. | Novartis | California | state | 2014 | $1,000,000 | tax credit/rebate | |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2016 | $1,000,000 | grant | |
Pfizer, Inc. | Pfizer | Michigan | state | 2019 | $1,000,000 | tax credit/rebate | |
IDEXX DIstribution, Inc. | IDEXX Laboratories | Kentucky | state | 2019 | $1,000,000 | tax credit/rebate | |
Novavax, Inc. | Novavax Inc. | Maryland | local | 2020 | $1,000,000 | grant/loan hybrid program | |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2012 | $999,077 | tax credit/rebate | |
Ironwood Pharmaceuticals, Inc | Ironwood Pharmaceuticals | Massachusetts | state | 2011 | $996,605 | tax credit/rebate | |
Merck Animal Health | Merck | Louisiana | state | 2012 | $995,624 | property tax abatement | |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2015 | $992,077 | tax credit/rebate | |
Regeneron Pharmaceuticals III | Regeneron Pharmaceuticals | New York | local | 2020 | $991,620 | tax credit/rebate | |
Forest Laboratories, Inc. and Forest Research | AbbVie | New Jersey | state | 2000 | $990,780 | grant | |
Shire Human Genetic Therapies | Takeda Pharmaceutical | Massachusetts | state | 2015 | $985,000 | tax credit/rebate | |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | $975,000 | tax credit/rebate | ||
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2013 | $973,073 | tax credit/rebate | |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2014 | $957,730 | tax credit/rebate | |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $955,302 | tax credit/rebate | |
Silarx Pharmaceuticals, Inc. | Lannett Co. | New York | state | 2015 | $952,757 | tax credit/rebate | |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2005 | $952,634 | tax credit/rebate | |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2012 | $952,032 | tax credit/rebate; property tax abatement | |
SmithKline Beecham Corporation DBA GlaxoSmithKline | GlaxoSmithKline | Pennsylvania | state | 2011 | $951,581 | tax credit/rebate | |
Regeneron 1CSC Office/Lab Extension | Regeneron Pharmaceuticals | New York | local | 2020 | $951,284 | tax credit/rebate | |
EMD Millipore Corporation | Merck KGaA (EMD) | California | state | 2018 | $945,000 | tax credit/rebate | |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2001 | $944,526 | enterprise zone | |
Pfizer Inc & Subsidiaries | Pfizer | Iowa | state | 2010 | $942,184 | tax credit/rebate | |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2003 | $939,077 | enterprise zone | |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2016 | $938,710 | tax credit/rebate | |
Doral/Pfizer | Pfizer | New York | local | 2009 | $932,710 | tax credit/rebate; property tax abatement | |
Dava Pharmaceuticals, Inc. | Endo International | New Jersey | state | 2004 | $931,560 | grant | |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | local | 2014 | $930,000 | grant | |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | Local | 2018 | $920,908 | tax credit/rebate | |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2014 | $914,646 | tax credit/rebate | |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $914,531 | enterprise zone | |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $914,531 | enterprise zone | |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2019 | $904,695 | tax credit/rebate | |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $903,866 | tax credit/rebate | |
ImClone Systems LLC | Eli Lilly | New York | state | 2012 | $901,984 | enterprise zone | |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $900,091 | tax credit/rebate | |
Synageva BioPharma Corp | AstraZeneca | Massachusetts | state | 2015 | $900,000 | tax credit/rebate | |
Boehringer Ingelheim Fremont Inc | Boehringer Ingelheim | California | state | 2021 | $898,743 | training reimbursement | |
Novozymes Blair, Inc. | Novo Holdings A/S | Nebraska | state | 2018 | $895,622 | tax credit/rebate | |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2020 | $894,247 | tax credit/rebate | |
Novartis Animal Health US, Inc. | Eli Lilly | North Carolina | state | 2015 | $885,684 | tax credit/rebate |